Skip to main content
Back
BUHPF logo

Bumrungrad Hospital Public Company Limited

Data quality: 100%
Overbought
BUHPF
OTC Healthcare Medical - Care Facilities
$5.65
$0.00 (0.00%)
Mkt Cap: 4.49B
Also listed as BUGDF OTC
Day Range
$5.65 $5.65
52-Week Range
$4.75 $5.65
Volume
300
50D / 200D Avg
$5.36 / $4.98
Prev Close
$5.65

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 0.6 0.4
P/B 0.2 2.9
ROE % 25.9 3.8
Net Margin % 29.9 3.9
Rev Growth 5Y % 19.2 10.0
D/E 0.0 0.2

Key Takeaways

Revenue grew 19.15% annually over 5 years — strong growth
ROE of 25.88% indicates high profitability
Net margin of 29.89% shows strong profitability
Debt/Equity of 0.02 — conservative balance sheet
Generating 6.59B in free cash flow
P/E of 0.60 — trading at a low valuation

Growth

Revenue Growth (5Y)
19.15%
Revenue (1Y)-2.35%
Earnings (1Y)-3.46%
FCF Growth (3Y)10.30%

Quality

Return on Equity
25.88%
ROIC21.22%
Net Margin29.89%
Op. Margin34.94%

Safety

Debt / Equity
0.02
Current Ratio4.60
Interest Coverage1324.95

Valuation

P/E Ratio
0.60
P/B Ratio0.15
EV/EBITDA-0.30
Dividend Yield0.03%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -2.35% Revenue Growth (3Y) -0.52%
Earnings Growth (1Y) -3.46% Earnings Growth (3Y) 3.50%
Revenue Growth (5Y) 19.15% Earnings Growth (5Y) 57.63%
Profitability
Revenue (TTM) 25.11B Net Income (TTM) 7.51B
ROE 25.88% ROA 20.60%
Gross Margin 50.52% Operating Margin 34.94%
Net Margin 29.89% Free Cash Flow (TTM) 6.59B
ROIC 21.22% FCF Growth (3Y) 10.30%
Safety
Debt / Equity 0.02 Current Ratio 4.60
Interest Coverage 1324.95 Dividend Yield 0.03%
Valuation
P/E Ratio 0.60 P/B Ratio 0.15
P/S Ratio 0.18 PEG Ratio -5.76
EV/EBITDA -0.30 Dividend Yield 0.03%
Market Cap 4.49B Enterprise Value -2.61B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 25.11B 25.72B 25.38B 20.72B 12.46B
Net Income 7.51B 7.77B 7.01B 4.94B 1.22B
EPS (Diluted) 8.51 8.96 8.08 5.69 1.40
Gross Profit 12.69B 13.21B 12.48B 9.62B 4.73B
Operating Income 8.77B 9.17B 8.50B 6.01B 1.52B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 36.43B 32.65B 29.21B 24.26B 20.86B
Total Liabilities 5.60B 4.85B 5.11B 4.25B 3.24B
Shareholders' Equity 30.52B 27.49B 23.80B 19.71B 17.29B
Total Debt 487.29M 139.44M 91.14M 63.28M 94.37M
Cash & Equivalents 7.59B 3.26B 3.77B 2.09B 1.80B
Current Assets 18.77B 16.73B 15.68B 11.42B 8.06B
Current Liabilities 4.08B 3.83B 4.18B 3.41B 2.28B

Strategy Scores

This stock passed the criteria for 4 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#352 of 820
46
Custom Contrarian Investing (David Dreman)
#433 of 658
19
Value Defensive Investing (Benjamin Graham)
#513 of 708
17
Value Value Investing (Warren Buffett)
#116 of 195
39

Recent Activity

Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered Contrarian Investing (David Dreman)
Mar 24, 2026
Entered Defensive Investing (Benjamin Graham)
Mar 24, 2026
Entered Value Investing (Warren Buffett)
Mar 24, 2026